Log In
Print
BCIQ
Print
Print this Print this
 

miR-21 (anti-miR-21) (RG-012) (formerly antagomir-21)

  Manage Alerts
Collapse Summary General Information
Company Regulus Therapeutics Inc.
DescriptionAntisense oligonucleotide targeting microRNA-21
Molecular Target MicroRNA-21 (miR-21)
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today